Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pfe crawled time : 00:20 save search
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
Published: 2023-11-25 (Crawled : 00:20) - prnewswire.com
PFE | News 4 | $26.25 -0.27% 9.9M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $731.81 -1.86% 1M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 52K
|
Health Technology
| Email alert
Add to watchlist
global market
U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
Published: 2023-10-13 (Crawled : 00:20) - biospace.com/
PFE | News 4 | $26.25 -0.27% 9.9M
|
Health Technology
|
| O: 0.06%
H: 0.15%
C: -2.52%
fda active
Worldwide Osteoarthritis Therapeutics Industry to 2029 - Increased Use of Pain Relievers and Growing Frequency of Osteoarthritis Drives Growth
Published: 2023-02-10 (Crawled : 00:20) - prnewswire.com
PFE | News 4 | $26.25 -0.27% 9.9M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.755 -1.18% 660K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 52K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.96 -0.59% 2.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.615 -2.25% 730K
|
Health Technology
| Email alert
Add to watchlist
ZBH | $121.645 0.1% 330K
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 2.6K
|
Health Technology
| Email alert
Add to watchlist
osteoarthritis growing therapeutics growth
Pfizer Declares First-Quarter 2023 Dividend
Published: 2022-12-09 (Crawled : 00:20) - biospace.com/
PFE | News 4 | $26.25 -0.27% 9.9M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.